Gustavo Gomez
Family Medicine · Lagrange, OHNPI 1699031088
Payments from drug & device makers
Across 92 payments — averaging $15.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$253
- Novo Nordisk$242
- Takeda Pharmaceuticals U.S.A., Inc.$222
- AbbVie$177
- Lilly USA, LLC$109
- Boehringer Ingelheim$74
- plus $378 from 12 others
What the payments were for
- Food & beverage$1,454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $253 |
| Novo Nordisk | 19 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $222 |
| AbbVie(2 entities) | 10 | $177 |
| Lilly USA, LLC | 7 | $109 |
| Boehringer Ingelheim | 5 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Pfizer | 4 | $53 |
| Astellas Pharma US Inc | 3 | $47 |
| Dexcom, Inc. | 2 | $41 |
| GSK | 2 | $40 |
| Shire North American Group Inc | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
How this compares
$1,454 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 73 | $112,508 |
| OzempicSemaglutide | 79 | $98,241 |
| JardianceEmpagliflozin | 65 | $78,723 |
| EliquisApixaban | 70 | $60,730 |
| Tresiba Flextouch U-100Insulin Degludec | 68 | $47,951 |
| FarxigaDapagliflozin Propanediol | 52 | $43,824 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $33,496 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $21,892 |
| RexultiBrexpiprazole | 13 | $18,897 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $17,251 |
| XareltoRivaroxaban | 18 | $15,469 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $14,461 |
| Spiriva RespimatTiotropium Bromide | 17 | $12,598 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $10,469 |
| Atorvastatin Calcium | 662 | $6,785 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Humalog | $109 | $114,55997 claims |
| Novo NordiskOzempic | $242 | $98,24179 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $74 | $91,32182 claims |
| PfizerEliquis | $53 | $60,73070 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $40 | $55,38882 claims |
| AstraZenecaFarxiga, Symbicort | $253 | $54,29382 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $66 | $18,89713 claims |
| Johnson & JohnsonXarelto | $11 | $15,46918 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $222 | $6,30113 claims |
| AbbVieSynthroid | $177 | $2,12551 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Lagrange
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.